Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077881> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2077881 endingPage "74" @default.
- W2077881 startingPage "465" @default.
- W2077881 abstract "To evaluate the impact of a therapeutic interchange from pravastatin to lovastatin on treatment outcomes, quality of life, patient satisfaction, and costs.A prospective cohort study of 170 patients switched from pravastatin to lovastatin from September 1997 through November 1997.The therapeutic interchange program promoting lovastatin as the preferred agent went into effect June 2, 1997 after Merck & Co. was awarded the Veterans Health Administration national contract for 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Patients were switched to lovastatin by either their primary care physician during routine clinic visits or the pharmacist by mail. The following outcomes were measured before and after conversion to lovastatin: lipid values, liver function tests, National Cholesterol Education Program (NCEP) low-density cholesterol (LDL-C) goals achieved, quality of life (QOL) (measured by the Medical Outcomes Study 36-item short-form health survey [SF-36]), medication tolerance (measured with a global symptom survey), patient satisfaction, and cost-minimization analysis.Lipid values and liver function test results were similar for pravastatin and lovastatin treatment. Forty percent of patients achieved NCEP LDL-C goals before and after formulary conversion. There were no significant differences between pravastatin and lovastatin in QOL, medication tolerance, and patient satisfaction. The projected cost savings from this therapeutic interchange was approximately $211,000 annually.Therapeutic interchange from pravastatin to lovastatin resulted in substantial cost savings. QOL, patient satisfaction, and achievement of NCEP LDL-C goals were maintained." @default.
- W2077881 created "2016-06-24" @default.
- W2077881 creator A5015564021 @default.
- W2077881 creator A5063576128 @default.
- W2077881 creator A5073569101 @default.
- W2077881 creator A5082711815 @default.
- W2077881 date "1999-04-01" @default.
- W2077881 modified "2023-09-26" @default.
- W2077881 title "Impact of therapeutic interchange from pravastatin to lovastatin in a Veterans Affairs Medical Center." @default.
- W2077881 cites W138462898 @default.
- W2077881 cites W2037377025 @default.
- W2077881 cites W2067978628 @default.
- W2077881 cites W2116404316 @default.
- W2077881 cites W2125967584 @default.
- W2077881 cites W2129750583 @default.
- W2077881 cites W2184899940 @default.
- W2077881 cites W2309298468 @default.
- W2077881 cites W2396742850 @default.
- W2077881 cites W2410428354 @default.
- W2077881 cites W2606392732 @default.
- W2077881 cites W614531583 @default.
- W2077881 cites W81234691 @default.
- W2077881 cites W2414576798 @default.
- W2077881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10387386" @default.
- W2077881 hasPublicationYear "1999" @default.
- W2077881 type Work @default.
- W2077881 sameAs 2077881 @default.
- W2077881 citedByCount "13" @default.
- W2077881 countsByYear W20778812012 @default.
- W2077881 countsByYear W20778812013 @default.
- W2077881 countsByYear W20778812016 @default.
- W2077881 countsByYear W20778812018 @default.
- W2077881 crossrefType "journal-article" @default.
- W2077881 hasAuthorship W2077881A5015564021 @default.
- W2077881 hasAuthorship W2077881A5063576128 @default.
- W2077881 hasAuthorship W2077881A5073569101 @default.
- W2077881 hasAuthorship W2077881A5082711815 @default.
- W2077881 hasConcept C100406419 @default.
- W2077881 hasConcept C104863432 @default.
- W2077881 hasConcept C126322002 @default.
- W2077881 hasConcept C2775969662 @default.
- W2077881 hasConcept C2776839432 @default.
- W2077881 hasConcept C2778163477 @default.
- W2077881 hasConcept C2778402494 @default.
- W2077881 hasConcept C2779457091 @default.
- W2077881 hasConcept C2779519902 @default.
- W2077881 hasConcept C2780578515 @default.
- W2077881 hasConcept C2780940807 @default.
- W2077881 hasConcept C511355011 @default.
- W2077881 hasConcept C512399662 @default.
- W2077881 hasConcept C71924100 @default.
- W2077881 hasConceptScore W2077881C100406419 @default.
- W2077881 hasConceptScore W2077881C104863432 @default.
- W2077881 hasConceptScore W2077881C126322002 @default.
- W2077881 hasConceptScore W2077881C2775969662 @default.
- W2077881 hasConceptScore W2077881C2776839432 @default.
- W2077881 hasConceptScore W2077881C2778163477 @default.
- W2077881 hasConceptScore W2077881C2778402494 @default.
- W2077881 hasConceptScore W2077881C2779457091 @default.
- W2077881 hasConceptScore W2077881C2779519902 @default.
- W2077881 hasConceptScore W2077881C2780578515 @default.
- W2077881 hasConceptScore W2077881C2780940807 @default.
- W2077881 hasConceptScore W2077881C511355011 @default.
- W2077881 hasConceptScore W2077881C512399662 @default.
- W2077881 hasConceptScore W2077881C71924100 @default.
- W2077881 hasIssue "4" @default.
- W2077881 hasLocation W20778811 @default.
- W2077881 hasOpenAccess W2077881 @default.
- W2077881 hasPrimaryLocation W20778811 @default.
- W2077881 hasRelatedWork W1839290569 @default.
- W2077881 hasRelatedWork W1873726896 @default.
- W2077881 hasRelatedWork W2022327948 @default.
- W2077881 hasRelatedWork W2036704593 @default.
- W2077881 hasRelatedWork W2042279251 @default.
- W2077881 hasRelatedWork W2060709766 @default.
- W2077881 hasRelatedWork W2071439026 @default.
- W2077881 hasRelatedWork W2077881 @default.
- W2077881 hasRelatedWork W2131512420 @default.
- W2077881 hasRelatedWork W2132096320 @default.
- W2077881 hasVolume "5" @default.
- W2077881 isParatext "false" @default.
- W2077881 isRetracted "false" @default.
- W2077881 magId "2077881" @default.
- W2077881 workType "article" @default.